# Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia

> **NCT00435045** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 245 (actual)

## Conditions studied

- Hypertriglyceridemia

## Interventions

- **DRUG:** Lovaza (omega-3-acid ethyl esters) [formerly known as Omacor] plus atorvastatin
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00435045
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435045, "Evaluation of Efficacy and Safety of Omacor, Co-Administered With Atorvastatin, in Subjects With Hypertriglyceridemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00435045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*